Wojciech Branicki

Prof. Dr. Wojciech Branicki

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Ageing Research Reviews
Verified
Journal Article
Closed access
RNRezvan Noroozi
Rezvan Noroozi
SGSoudeh Ghafouri-Fard
Soudeh Ghafouri-Fard
APAleksandra Pisarek
Aleksandra Pisarek
JRJoanna Rudnicka
Joanna Rudnicka
MSMagdalena Spólnicka
Magdalena Spólnicka
EPEwelina Pośpiech
Ewelina Pośpiech

1 November 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
SGSoudeh Ghafouri-Fard
Soudeh Ghafouri-Fard
AAAtefe Abak
Atefe Abak
STSeyedeh Fahimeh Talebi
Seyedeh Fahimeh Talebi
HSHamed Shoorei
Hamed Shoorei
WBWojciech Branicki
Wojciech Branicki
NDNader Akbari Dilmaghani
Nader Akbari Dilmaghani
Fibrosis is the endpoint of pathological remodeling. This process contributes to the pathogenesis of several chronic disorders and aging-associated organ damage. Different molecular cascades contribute to this process. TGF-β, WNT, and YAP/TAZ signaling pathways have prominent roles in this process. A number of long non-coding RNAs and microRNAs have been found to regulate organ fibrosis through modulation of the activity of related signaling pathways. miR-144-3p, miR-451, miR-200b, and miR-328 are among microRNAs that participate in the pathology of cardiac fibrosis. Meanwhile, miR-34a, miR-17-5p, miR-122, miR-146a, and miR-350 contribute to liver fibrosis in different situations. PVT1, MALAT1, GAS5, NRON, PFL, MIAT, HULC, ANRIL, and H19 are among long non-coding RNAs that participate in organ fibrosis. We review the impact of long non-coding RNAs and microRNAs in organ fibrosis and aging-related pathologies.

11 March 2021 in Aging
Verified
Journal Article
Open access
AWAnna Woźniak
Anna Woźniak
VCVISAGE Consortium
VISAGE Consortium
AHAntonia Heidegger
Antonia Heidegger
DPDanuta Piniewska-Róg
Danuta Piniewska-Róg
EPEwelina Pośpiech
Ewelina Pośpiech
WBWojciech Branicki
Wojciech Branicki
DNA methylation is known as a biomarker for age with applications in forensics. Here we describe the VISAGE (VISible Attributes through GEnomics) Consortium's enhanced tool for epigenetic age estimation in somatic tissues. The tool is based on eight DNA methylation markers (44 CpGs), bisulfite multiplex PCR followed by sequencing on the MiSeq FGx platform, and three statistical prediction models for blood, buccal cells and bones. The model for blood is based on six CpGs from ELOVL2, MIR29B2CHG, KLF14, FHL2, TRIM59 and PDE4C, and predicts age with a mean absolute error (MAE) of 3.2 years, while the model for buccal cells includes five CpGs from PDE4C, MIR29B2CHG, ELOVL2, KLF14 and EDARADD and predicts age with MAE of 3.7 years, and the model for bones has six CpGs from ELOVL2, KLF14, PDE4C and ASPA and predicts age with MAE of 3.4 years. The VISAGE enhanced tool for age estimation in somatic tissues enables reliable collection of DNA methylation data from small amounts of DNA using a sensitive multiplex MPS assay that provides accurate estimation of age in blood, buccal swabs, and bones using the statistical model tailored to each tissue.

19 July 2017 in International journal of legal medicine
Verified
Journal Article
Open access
PDF file
MSM. Spólnicka
M. Spólnicka
EPE. Pośpiech
E. Pośpiech
BBBeata Borzemska
Beata Borzemska
RZR. Zbieć-Piekarska
R. Zbieć-Piekarska
ŻMŻ. Makowska
Ż. Makowska
WBWojciech Branicki
Wojciech Branicki
Improving accuracy of the available predictive DNA methods is important for their wider use in routine forensic work. Information on age in the process of identification of an unknown individual may provide important hints that can speed up the process of investigation. DNA methylation markers have been demonstrated to provide accurate age estimation in forensics, but there is growing evidence that DNA methylation can be modified by various factors including diseases. We analyzed DNA methylation profile in five markers from five different genes (ELOVL2, C1orf132, KLF14, FHL2, and TRIM59) used for forensic age prediction in three groups of individuals with diagnosed medical conditions. The obtained results showed that the selected age-related CpG sites have unchanged age prediction capacity in the group of late onset Alzheimer’s disease patients. Aberrant hypermethylation and decreased prediction accuracy were found for TRIM59 and KLF14 markers in the group of early onset Alzheimer’s disease suggesting accelerated aging of patients. In the Graves’ disease patients, altered DNA methylation profile and modified age prediction accuracy were noted for TRIM59 and FHL2 with aberrant hypermethylation observed for the former and aberrant hypomethylation for the latter. Our work emphasizes high utility of the ELOVL2 and C1orf132 markers for prediction of chronological age in forensics by showing unchanged prediction accuracy in individuals affected by three diseases. The study also demonstrates that artificial neural networks could be a convenient alternative for the forensic predictive DNA analyses.

17 July 2023 in Military Medical Research
Verified
Journal Article
Open access
PDF file
BMBashdar Mahmud
Bashdar Mahmud
MRMohammed Fatih Rasul
Mohammed Fatih Rasul
SASnur Rasool Abdullah
Snur Rasool Abdullah
HHHazha Jamal Hidayat
Hazha Jamal Hidayat
GFGoran Sedeeq Hama Faraj
Goran Sedeeq Hama Faraj
Mohammad TaheriMohammad Taheri
Mohammad Taheri
Clustered regulatory interspaced short palindromic repeats (CRISPR) has changed biomedical research and provided entirely new models to analyze every aspect of biomedical sciences during the last decade. In the study of cancer, the CRISPR/CRISPR-associated protein (Cas) system opens new avenues into issues that were once unknown in our knowledge of the noncoding genome, tumor heterogeneity, and precision medicines. CRISPR/Cas-based gene-editing technology now allows for the precise and permanent targeting of mutations and provides an opportunity to target small non-coding RNAs such as microRNAs (miRNAs). However, the development of effective and safe cancer gene editing therapy is highly dependent on proper design to be innocuous to normal cells and prevent introducing other abnormalities. This study aims to highlight the cutting-edge approaches in cancer-gene editing therapy based on the CRISPR/Cas technology to target miRNAs in cancer therapy. Furthermore, we highlight the potential challenges in CRISPR/Cas-mediated miRNA gene editing and offer advanced strategies to overcome them.

22 May 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMagdalena Marcińska
Magdalena Marcińska
EPEwelina Pośpiech
Ewelina Pośpiech
SASarah Abidi
Sarah Abidi
JAJeppe D. Andersen
Jeppe D. Andersen
MBMargreet van Den Berge
Margreet van Den Berge
WBWojciech Branicki
Wojciech Branicki
Androgenetic alopecia, known in men as male pattern baldness (MPB), is a very conspicuous condition that is particularly frequent among European men and thus contributes markedly to variation in physical appearance traits amongst Europeans. Recent studies have revealed multiple genes and polymorphisms to be associated with susceptibility to MPB. In this study, 50 candidate SNPs for androgenetic alopecia were analyzed in order to verify their potential to predict MPB. Significant associations were confirmed for 29 SNPs from chromosomes X, 1, 5, 7, 18 and 20. A simple 5-SNP prediction model and an extended 20-SNP model were developed based on a discovery panel of 305 males from various European populations fitting one of two distinct phenotype categories. The first category consisted of men below 50 years of age with significant baldness and the second; men aged 50 years or older lacking baldness. The simple model comprised the five best predictors: rs5919324 near AR, rs1998076 in the 20p11 region, rs929626 in EBF1, rs12565727 in TARDBP and rs756853 in HDAC9. The extended prediction model added 15 SNPs from five genomic regions that improved overall prevalence-adjusted predictive accuracy measured by area under the receiver characteristic operating curve (AUC). Both models were evaluated for predictive accuracy using a test set of 300 males reflecting the general European population. Applying a 65% probability threshold, high prediction sensitivity of 87.1% but low specificity of 42.4% was obtained in men aged <50 years. In men aged ≥50, prediction sensitivity was slightly lower at 67.7% while specificity reached 90%. Overall, the AUC=0.761 calculated for men at or above 50 years of age indicates these SNPs offer considerable potential for the application of genetic tests to predict MPB patterns, adding a highly informative predictive system to the emerging field of forensic analysis of externally visible characteristics.